These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9721432)

  • 1. Emerging strategies for the clinical application of rapamycin.
    Kahan BD
    Clin Biochem; 1998 Jul; 31(5):341-4. PubMed ID: 9721432
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
    Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
    Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus, a potent new immunosuppressive drug for organ transplantation.
    Stepkowski SM
    Ann Transplant; 1996; 1(3):19-25. PubMed ID: 9869915
    [No Abstract]   [Full Text] [Related]  

  • 4. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
    Kreis H; Cisterne JM; Land W; Wramner L; Squifflet JP; Abramowicz D; Campistol JM; Morales JM; Grinyo JM; Mourad G; Berthoux FC; Brattström C; Lebranchu Y; Vialtel P
    Transplantation; 2000 Apr; 69(7):1252-60. PubMed ID: 10798738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin reduces rejection in heart transplant recipients.
    Radovancevic B; El-Sabrout R; Thomas C; Radovancevic R; Frazier OH; Van Buren C
    Transplant Proc; 2001; 33(7-8):3221-2. PubMed ID: 11750381
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection.
    Mathew TH; Van Buren C; Kahan BD; Butt K; Hariharan S; Zimmerman JJ
    J Clin Pharmacol; 2006 Jan; 46(1):76-87. PubMed ID: 16397287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus antirejection therapy for renal transplantation with cyclosporine-based immunosuppression: case reports.
    Tsai MK; Hu RH; Lee PH
    Transplant Proc; 2003 Feb; 35(1):219-20. PubMed ID: 12591371
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus for solid organ transplantation in children.
    Gupta P; Kaufman S; Fishbein TM
    Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibody.
    Kerman RH; Katz SM; Van Buren CT; Garcia C; Kahan BD
    Transplant Proc; 2001; 33(1-2):401. PubMed ID: 11266881
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
    Longoria J; Roberts RF; Marboe CC; Stouch BC; Starnes VA; Barr ML
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):714-8. PubMed ID: 10096966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships.
    Mueller EA; Niese D; Mellein B
    Transplant Proc; 1998 Aug; 30(5):1694-6. PubMed ID: 9723247
    [No Abstract]   [Full Text] [Related]  

  • 15. Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
    Drugs R D; 1999 Jan; 1(1):100-7. PubMed ID: 10566001
    [No Abstract]   [Full Text] [Related]  

  • 16. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
    Vathsala A; Lu YM
    Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
    [No Abstract]   [Full Text] [Related]  

  • 17. International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring.
    Holt DW; Armstrong VW; Griesmacher A; Morris RG; Napoli KL; Shaw LM; ; ;
    Ther Drug Monit; 2002 Feb; 24(1):59-67. PubMed ID: 11805724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
    Cowan PA; Heizer KE
    Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].
    Royer B; Davani S; Bérard M; Kantelip JP; Muret P
    Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.